|
MTMR15 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62525548574877E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.33226762955019E-15 |
| Normal-vs-Stage2 |
6.20380002924747E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62836411021772E-12 |
| Stage1-vs-Stage2 |
1.012780E-01 |
| Stage1-vs-Stage3 |
1.255750E-01 |
| Stage1-vs-Stage4 |
1.783440E-01 |
| Stage2-vs-Stage3 |
1.096010E-02 |
| Stage2-vs-Stage4 |
2.774400E-02 |
| Stage3-vs-Stage4 |
8.718000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
4.2613999995389E-07 |
| Normal-vs-Asian |
7.59392548843607E-14 |
| Caucasian-vs-AfricanAmerican |
1.022360E-01 |
| Caucasian-vs-Asian |
4.887600E-01 |
| AfricanAmerican-vs-Asian |
3.157600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.6251444634463E-12 |
| Male-vs-Female |
7.506200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.7715611723761E-16 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
1.85065999999123E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.996800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.838400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.928000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.266800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.682400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.171600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.82800000001227E-06 |
| Classical-VS-Follicular |
4.324100E-03 |
| Classical-VS-Other |
5.671800E-01 |
| Classical-VS-Normal |
1.62836411021772E-12 |
| Tall-VS-Follicular |
2.14159999734065E-08 |
| Tall-VS-Other |
4.995500E-03 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
7.219400E-01 |
| Follicular-VS-Normal |
5.95812288395337E-12 |
| Other-VS-Normal |
9.579800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62458935193399E-12 |
| N0-vs-N1 |
4.079800E-02 |
|
|
